Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

26.26
Delayed Data
As of Jun 28
 +0.85 / +3.35%
Today’s Change
15.15
Today|||52-Week Range
32.97
+57.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues186.5M177.5M196.5M196.9M
 
 
 
 
 
Cost of Goods Sold33.3M30.8M31.4M31.4M
 
 
 
 
 
Depreciation And Amortization6.7M9.2M13.0M12.9M
 
 
 
 
 
 
Operating ExpensesGross Income146.5M137.5M152.1M152.6M
 
 
 
 
 
General Expenses110.8M131.3M137.6M138.0M
 
 
 
 
 
Research And Development19.5M19.4M18.6M17.6M
 
 
 
 
 
Total Operating Expenses150.8M171.3M182.0M182.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income35.7M6.2M14.5M14.6M
 
 
 
 
 
Extraordinary Charge0.000.00-1.3M-6.9M
 
 
 
Interest Expense On Debt0.00--2.6M1.5M
 
 
 
Other Expenses1.2M-2.5M1.2M1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income37.3M4.0M12.1M8.0M
 
 
 
 
 
Income Taxes-13.9M-5.2M-6.2M-3.8M
 
 
 
 
 
Net Income23.4M-1.2M5.9M4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.0M68.8M68.2M68.1M
 
 
 
 
 
Shares To Calculate EPS Diluted72.4M68.8M68.3M68.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.32-$0.02$0.09$0.06
 
 
 
 
 
EPS Diluted$0.32-$0.02$0.09$0.06